CHX logo

ChampionX (CHX) EBITDA

annual EBITDA:

$744.57M+$30.25M(+4.23%)
December 31, 2024

Summary

  • As of today (July 3, 2025), CHX annual EBITDA is $744.57 million, with the most recent change of +$30.25 million (+4.23%) on December 31, 2024.
  • During the last 3 years, CHX annual EBITDA has risen by +$302.68 million (+68.50%).
  • CHX annual EBITDA is now at all-time high.

Performance

CHX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCHXincome statement metrics

quarterly EBITDA:

$177.66M-$15.36M(-7.96%)
March 31, 2025

Summary

  • As of today (July 3, 2025), CHX quarterly EBITDA is $177.66 million, with the most recent change of -$15.36 million (-7.96%) on March 31, 2025.
  • Over the past year, CHX quarterly EBITDA has dropped by -$35.61 million (-16.70%).
  • CHX quarterly EBITDA is now -16.70% below its all-time high of $213.27 million, reached on March 31, 2024.

Performance

CHX quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCHXincome statement metrics

TTM EBITDA:

$708.96M-$35.61M(-4.78%)
March 31, 2025

Summary

  • As of today (July 3, 2025), CHX TTM EBITDA is $708.96 million, with the most recent change of -$35.61 million (-4.78%) on March 31, 2025.
  • Over the past year, CHX TTM EBITDA has dropped by -$57.64 million (-7.52%).
  • CHX TTM EBITDA is now -7.52% below its all-time high of $766.60 million, reached on March 31, 2024.

Performance

CHX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCHXincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CHX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.2%-16.7%-7.5%
3 y3 years+68.5%+56.4%+49.7%
5 y5 years+240.9%+128.6%+221.6%

CHX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+68.5%-16.7%+81.7%-7.5%+61.0%
5 y5-yearat high+249.9%-16.7%+502.3%-7.5%+221.6%
alltimeall timeat high+249.9%-16.7%+128.6%-7.5%+221.6%

CHX EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$177.66M(-8.0%)
$708.96M(-4.8%)
Dec 2024
$744.57M(+4.2%)
$193.02M(+7.6%)
$744.57M(+0.9%)
Sep 2024
-
$179.39M(+12.9%)
$737.99M(-0.8%)
Jun 2024
-
$158.88M(-25.5%)
$743.98M(-3.0%)
Mar 2024
-
$213.27M(+14.4%)
$766.60M(+7.3%)
Dec 2023
$714.32M(+47.6%)
$186.45M(+0.6%)
$714.32M(+3.4%)
Sep 2023
-
$185.38M(+2.1%)
$690.89M(+12.3%)
Jun 2023
-
$181.50M(+12.7%)
$614.97M(+15.8%)
Mar 2023
-
$160.99M(-1.2%)
$531.25M(+9.8%)
Dec 2022
$483.89M(+9.5%)
$163.02M(+48.9%)
$483.89M(+9.9%)
Sep 2022
-
$109.46M(+11.9%)
$440.35M(-9.5%)
Jun 2022
-
$97.79M(-13.9%)
$486.72M(+2.7%)
Mar 2022
-
$113.63M(-4.9%)
$473.73M(+7.2%)
Dec 2021
$441.89M(-189.0%)
$119.47M(-23.3%)
$441.89M(+4.7%)
Sep 2021
-
$155.83M(+83.8%)
$422.02M(+25.7%)
Jun 2021
-
$84.80M(+3.7%)
$335.68M(+62.4%)
Mar 2021
-
$81.79M(-17.9%)
$206.72M(-141.6%)
DateAnnualQuarterlyTTM
Dec 2020
-$496.66M(-327.4%)
$99.60M(+43.3%)
-$496.66M(-12.5%)
Sep 2020
-
$69.49M(-257.4%)
-$567.50M(-2.6%)
Jun 2020
-
-$44.16M(-92.9%)
-$582.82M(+24.2%)
Mar 2020
-
-$621.59M(-2261.2%)
-$469.11M(-314.8%)
Dec 2019
$218.43M(-20.1%)
$28.76M(-46.9%)
$218.43M(-15.6%)
Sep 2019
-
$54.17M(-22.1%)
$258.71M(-7.1%)
Jun 2019
-
$69.55M(+5.5%)
$278.56M(+0.1%)
Mar 2019
-
$65.95M(-4.5%)
$278.36M(+1.8%)
Dec 2018
$273.46M(+35.3%)
$69.05M(-6.7%)
$273.46M(+9.6%)
Sep 2018
-
$74.02M(+6.7%)
$249.59M(+7.9%)
Jun 2018
-
$69.34M(+13.6%)
$231.27M(+6.7%)
Mar 2018
-
$61.05M(+35.1%)
$216.74M(+5.7%)
Dec 2017
$202.08M(+115.8%)
$45.18M(-18.9%)
$204.96M(+28.3%)
Sep 2017
-
$55.70M(+1.6%)
$159.78M(+53.5%)
Jun 2017
-
$54.81M(+11.2%)
$104.08M(+111.2%)
Mar 2017
-
$49.27M
$49.27M
Dec 2016
$93.65M(-55.2%)
-
-
Dec 2015
$208.91M
-
-

FAQ

  • What is ChampionX annual EBITDA?
  • What is the all time high annual EBITDA for ChampionX?
  • What is ChampionX annual EBITDA year-on-year change?
  • What is ChampionX quarterly EBITDA?
  • What is the all time high quarterly EBITDA for ChampionX?
  • What is ChampionX quarterly EBITDA year-on-year change?
  • What is ChampionX TTM EBITDA?
  • What is the all time high TTM EBITDA for ChampionX?
  • What is ChampionX TTM EBITDA year-on-year change?

What is ChampionX annual EBITDA?

The current annual EBITDA of CHX is $744.57M

What is the all time high annual EBITDA for ChampionX?

ChampionX all-time high annual EBITDA is $744.57M

What is ChampionX annual EBITDA year-on-year change?

Over the past year, CHX annual EBITDA has changed by +$30.25M (+4.23%)

What is ChampionX quarterly EBITDA?

The current quarterly EBITDA of CHX is $177.66M

What is the all time high quarterly EBITDA for ChampionX?

ChampionX all-time high quarterly EBITDA is $213.27M

What is ChampionX quarterly EBITDA year-on-year change?

Over the past year, CHX quarterly EBITDA has changed by -$35.61M (-16.70%)

What is ChampionX TTM EBITDA?

The current TTM EBITDA of CHX is $708.96M

What is the all time high TTM EBITDA for ChampionX?

ChampionX all-time high TTM EBITDA is $766.60M

What is ChampionX TTM EBITDA year-on-year change?

Over the past year, CHX TTM EBITDA has changed by -$57.64M (-7.52%)
On this page